A prospective cohort study assessing the Renin and ACE as biomarkers for response to Angiotensin II (Giapreza) in patients with Septic Shock and Acute Kidney Injury
Latest Information Update: 27 Jun 2021
At a glance
- Drugs Angiotensin II (Primary) ; Vasopressors
- Indications Acute kidney injury; Septic shock
- Focus Pharmacodynamics
- 27 Jun 2021 New trial record
- 19 May 2021 Results presented at the 117th International Conference of the American Thoracic Society